for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Updated

BRIEF-Assertio Therapeutics Posts Fourth-Quarter Loss Per Share Of $2.65

By Reuters Staff

March 9 (Reuters) - Assertio Therapeutics Inc:

* ASSERTIO THERAPEUTICS ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

* ASSERTIO THERAPEUTICS INC - QTRLY LOSS PER SHARE $2.65

* ASSERTIO THERAPEUTICS INC - QTRLY ADJUSTED LOSS PER SHARE $0.14

* ASSERTIO THERAPEUTICS INC - QTRLY TOTAL REVENUES $59.2 MILLION Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up